Dual-energy x-ray absorptiometry in osteopetrosis.
We have used dual-energy x-ray absorptiometry (DXA) in evaluation and follow-up of a patient with osteopetrosis, before and after cord blood transplantation. Other methods of follow-up in such cases have been described, but the use of DXA has not previously been reported. We have shown that DXA offers a safe means of assessing disease progression, the timing of treatment, and response after therapy for osteopetrosis.
Adler
I N
IN
Department of Radiology, Arkansas Children's Hospital, Little Rock, USA.
Stine
K C
KC
Kurtzburg
J
J
Kinder
D L
DL
Cox
K S
KS
Lensing
S Y
SY
Seibert
J J
JJ
D015502:Absorptiometry, Photon; D000276:Adjuvants, Immunologic / Q000627:therapeutic use; D001803:Blood Transfusion; D018450:Disease Progression; D004872:Ergocalciferols / Q000627:therapeutic use; D005312:Fetal Blood; D005500:Follow-Up Studies; D006801:Humans; D007223:Infant; D007371:Interferon-gamma / Q000627:therapeutic use; D008297:Male; D010022:Osteopetrosis / Q000175:diagnosis* / Q000188:drug therapy / Q000628:therapy; D013997:Time Factors; D016896:Treatment Outcome
D000276:Adjuvants, Immunologic; D004872:Ergocalciferols; D007371:Interferon-gamma